fpl-52694 has been researched along with calcimycin in 1 studies
| Studies (fpl-52694) | Trials (fpl-52694) | Recent Studies (post-2010) (fpl-52694) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 25 | 1 | 1 | 11,946 | 40 | 444 |
| Protein | Taxonomy | fpl-52694 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, S; Ohtsuki, H; Okabe, S; Takeuchi, K | 1 |
1 other study(ies) available for fpl-52694 and calcimycin
| Article | Year |
|---|---|
Characterization of FPL-52694 [5-(2-hydroxypropoxyl)-8-propyl-4-oxo-4H-benzopyran-2-carboxylic acid Na] on histamine release from rat peritoneal mast cells induced by antigen, compound 48/80 and A 23187.
Topics: Animals; Antigens; Ascaris; Calcimycin; Chromones; Cromolyn Sodium; Dose-Response Relationship, Drug; Histamine Release; In Vitro Techniques; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Rats; Rats, Inbred Strains | 1985 |